AU2002217091A1 - Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis - Google Patents

Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis

Info

Publication number
AU2002217091A1
AU2002217091A1 AU2002217091A AU1709102A AU2002217091A1 AU 2002217091 A1 AU2002217091 A1 AU 2002217091A1 AU 2002217091 A AU2002217091 A AU 2002217091A AU 1709102 A AU1709102 A AU 1709102A AU 2002217091 A1 AU2002217091 A1 AU 2002217091A1
Authority
AU
Australia
Prior art keywords
angiogenesis
methylation
diagnosis
determining
diseases associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217091A
Inventor
Oliver Schacht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics AG filed Critical Epigenomics AG
Publication of AU2002217091A1 publication Critical patent/AU2002217091A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002217091A 2000-12-06 2001-12-06 Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis Abandoned AU2002217091A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10061338A DE10061338A1 (en) 2000-12-06 2000-12-06 Diagnosis of diseases associated with angiogenesis
DE10061338.1 2000-12-06
PCT/EP2001/014320 WO2002046454A2 (en) 2000-12-06 2001-12-06 Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis

Publications (1)

Publication Number Publication Date
AU2002217091A1 true AU2002217091A1 (en) 2002-06-18

Family

ID=7666455

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217091A Abandoned AU2002217091A1 (en) 2000-12-06 2001-12-06 Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis

Country Status (5)

Country Link
US (1) US20040142334A1 (en)
EP (1) EP1402059A2 (en)
AU (1) AU2002217091A1 (en)
DE (1) DE10061338A1 (en)
WO (1) WO2002046454A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7617163B2 (en) * 1998-05-01 2009-11-10 Health Discovery Corporation Kernels and kernel methods for spectral data
DE10245779A1 (en) * 2002-10-01 2004-04-29 Epigenomics Ag Predicting responsiveness of a subject with breast cell proliferative disorder, useful for treating or differentiating breast cell proliferative disorders comprises analyzing methylation pattern of a genomic DNA from the subject
US7932027B2 (en) 2005-02-16 2011-04-26 Epigenomics Ag Method for determining the methylation pattern of a polynucleic acid
WO2006088978A1 (en) 2005-02-16 2006-08-24 Epigenomics, Inc. Method for determining the methylation pattern of a polynucleic acid
PT1871912E (en) 2005-04-15 2012-05-25 Epigenomics Ag Method for determining dna methylation in blood or urine samples
WO2006111586A2 (en) * 2005-04-20 2006-10-26 Proyecto De Biomedicina Cima, S.L. Method for the in vitro determination of the degree of methylation of the line-1 promoter
US8084734B2 (en) * 2006-05-26 2011-12-27 The George Washington University Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays
US20100234381A1 (en) * 2007-04-13 2010-09-16 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
US8110796B2 (en) 2009-01-17 2012-02-07 The George Washington University Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays
US9490113B2 (en) * 2009-04-07 2016-11-08 The George Washington University Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
AU2012209185B2 (en) * 2011-01-25 2016-06-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of diagnosing and treating age-related macular degeneration
WO2013033627A2 (en) * 2011-09-01 2013-03-07 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
US11414704B2 (en) 2016-06-08 2022-08-16 University Of Iowa Research Foundation Compositions and methods for detecting predisposition to cardiovascular disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
AU7829398A (en) * 1997-06-09 1998-12-30 University Of Southern California A cancer diagnostic method based upon dna methylation differences
DE19754482A1 (en) * 1997-11-27 1999-07-01 Epigenomics Gmbh Process for making complex DNA methylation fingerprints
ATE217028T1 (en) * 1997-12-05 2002-05-15 Max Planck Gesellschaft METHOD FOR IDENTIFYING NUCLEIC ACIDS BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY
AU4158799A (en) * 1998-06-06 1999-12-30 Genostic Pharma Limited Probes used for genetic filing
JP2003528564A (en) * 1998-06-06 2003-09-30 ジェノスティック ファーマ リミテッド Probes used for genetic profiling
DE19905082C1 (en) * 1999-01-29 2000-05-18 Epigenomics Gmbh Identification of methylation patterns of cytosine in genome DNA comprises chemical treatment to produce different base pairing behavior between cytosine and 5-methylcytosine
WO2002000926A2 (en) * 2000-06-30 2002-01-03 Epigenomics Ag Diagnosis of diseases associated with signal transduction
ES2299520T3 (en) * 2000-09-01 2008-06-01 Epigenomics Ag PROCEDURE FOR THE DETERMINATION OF THE DEGREE OF METHYLATION OF CERTAIN CITOSINES IN GENOMIC DNA IN THE SEQUENTIAL CONTEXT 5'-CPG-3 '.

Also Published As

Publication number Publication date
EP1402059A2 (en) 2004-03-31
DE10061338A1 (en) 2002-06-20
WO2002046454A2 (en) 2002-06-13
US20040142334A1 (en) 2004-07-22
WO2002046454A3 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2001287575A1 (en) Diagnosis of diseases associated with the immune system by determining cytosine methylation
MXPA03002814A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases.
AU2001280796A1 (en) Electrowetting-driven micropumping
AU2001296978A1 (en) Temperature measuring balloon
AU3928300A (en) Genes associated with diseases of the kidney
AU2002303594A1 (en) Thermography catheter
AU2002217091A1 (en) Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis
AU3479700A (en) Genes associated with diseases of the colon
AU7408301A (en) Novel target genes for diseases of the heart
AU7053300A (en) Double-fired horizontal tube heater
AU2002218283A1 (en) Diagnosis of diseases associated with cdk4 by determining the methyl delivery state of cdk4
AU2002210438A1 (en) Diagnosis of diseases which are associated with cd24
AU2001244358A1 (en) Schizophrenia related genes
AU2001277997A1 (en) Diagnostic polymorphisms for the tgf-beta1 promoter
AU2001229768A1 (en) Amplified genes at 17q23
AU2001296300A1 (en) Haplotypes of the ccr6 gene
AU2001278042A1 (en) Daz genes
AU2003219725A1 (en) Angiogenesis genes
AU2001281123A1 (en) Haplotypes of the isl1 gene
AU2001257021A1 (en) Haplotypes of the cyp8b1 gene
AU4453301A (en) Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
AU2002357964A1 (en) Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases
AU2001253101A1 (en) Haplotypes of the scn2b gene
AU2002239511A1 (en) Haplotypes of the gsr gene
AU2001251243A1 (en) Haplotypes of the chrnb2 gene

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application